Week 8 - Cannabis Flashcards

1
Q

Cannabis plant

A
  • Cannabis sativa
  • plants vary in size; male and female plants
  • female plant must fertilized by pollen from male plant to generate seeds
  • female plant produces sticky resin at top to attract pollen and protect seeds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Active ingredient in cannabis

A
  • over 60 cannabinoids (all found only in cannabis)
  • amount of delta-9-THC depends on preparation, route of admin and inactive ingredients altering potency or metabolism
  • all parts of plant contain THC
  • burning cannabis, GI digestion & metabolism can create new cannabinoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Forms of cannabis

A

marijuana: dried leaves & flowers; usually smoked (joint or bong)
hashish: dried resin from female plant; usually smoked, eaten (foods)
hash oil: hashish boiled in alcohol, then residue is filteres & alcohol evaporated; can be smoked
concentrates: extracts (dabs, wax, shatter) use butane hash oil as solvent & vaporised in small quantities (high THC)
edibles: foods containing cannabis
medicinal cannabis - TGA approved, capsules/oral solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

THC content of plants

A

changes over time
60s - 1.5%
90s - 3.5 - 4.5%
2008 - 10%
can be as high as 30% but typically contain 3-15% THC
industrial hemp contains < 0.5-1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

uses of cannabis

A
  • fibre (clothes, textiles, paper, rope)
  • oil (lamp oil & food) and as an active ingredient in the manufacturing of soap, paint & varnish
  • medicinal purposes
  • psychoactive properties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmaceutical canabinoids

A
  • Marinol & nabilone: to alleviate nausea and vomiting in people w/ cancer; anorexia & weightloss assoc AIDS
  • sativex: neuropathic pain assoc multiple sclerosis
  • epidyolex: seizures assoc rare epileptic disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

historical medical uses

A
  • rheumatism
  • mania
  • whooping cough
  • asthma
  • bronchitis
  • spasms
  • epilepsy
  • convulsions
  • palsy
  • uterine haemorrhage
  • dysmenorrhea
  • hysteria
  • alcohol withdrawal
  • loss of appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oral administration

A

slow absorption by this route, but long duration of effect - affected by first pass metbolism by liver
- not ionized pKa = 10.6
- extremely lipid soluble
- onset of action: 30-90mins >ingestion
- peak: 1-4hrs after ingestions; psychoactive effects may last 4-12hrs, appetite >24hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inhalation

A

readily and rapidly absorbed
- 10-25% of cannabinoids reach general blood circulation from lungs
- peak blood levels <10 mins; peak effects: lags about 30 mins
- holding smoke does not increase absorption
- depth and frequency of inhalation may alter THC absorption
- vaporizers now popular method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

distribution

A
  • distributed to all areas of body (capable of altering all biological systems)
  • concentrated in lungs, kidneys, liver
  • ~1% enters the brain but levels continue to increase after ingestion & peak blood levels
  • crosses placenta and is present in breat milk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

excretion

A
  • initial metabolism in lungs or gastrointestinal tract depending on admin
  • most metabolism in liver; CYP450 enxymes
  • delta-9-thc and 11-hydroxy-delta-9-THC are more lipid soluble and harder to excrete than other metabolites (> 100)
  • 11-hyroxy-delta-9-THC is more active than delta-9-THC and penetrates BBB easier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

metabolism of other cannbinoids

A

cannabidiol (CBD) - 20 metabolites
- blocks enzyme that metabolizes THC
cannabinol (CBN) - 20 metabolites
- increases metabolism of THC
- possible interaction effects between THC, CBN & CBD to displce THC from blood binding sites (increases amount available for distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

excretion: THC

A

Phase 1:
- 1/2 life ~ 30-80 minutes; redistribution effect
Phase 2:
- 1/2 life ~ 20-30 hours; metabolism effect
- slow metabolism due to lipid solubility & speed that THC is released from fatty tissues - traces of THC can be detected 1-4 weeks after ingestion
- excreted in feces (65%) and urine (20&
- effects of frequent use on metabolism unclear
CBD half life 9-32 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Receptor sites

A
  • 2 known types of cannabinoid receptors (CB1 & CB2)
  • work on second messengers & neuromodulators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CB1

A
  • Located in CNS
  • uneven distribution of receptors in the CNS
  • most in higher centres therefore affect memory, emotional expression, mental processes; but also affect movement, appetite & analgesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CB2

A
  • mostly outside the CNS in spleen & immune system; could account for effects on immune functioning
  • in CNS ; glial cells, stem-like cells and other brain areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Endogenous Ligands (endocannabinoids)

A
  • anandamide
  • fat soluble, but simpler molecular structure
  • exact function unkown
  • discovery has lead to abundance of research
    function of endocannabinoids: relax, eat, sleep, forget & protect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

THC & endocannabinoids alter the functioning of

A

GABA, NE, DA, seratonin (5-HT), ACh, histamines, glutamate & opiod peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how are endocannabinoids synthesized?

A

on-demand in dendrites & cell body then released, cross synapse & bind to presynaptic CB1 receptors - due to binding they have a retrograde action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is retrograde action?

A

allows the postsynaptic neuron to shut down presynaptic neuron which causes a depolarization induced suppression of inhibition and excitation (DSI & DSE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

3 types of neuromodulation

A

Increased synthesis of:
- NE
- DA
- 5-HT
- GABA
alter receptors for:
- NE
- ACh
- DA
- potentiate action of:
- NE
- ACh
- DA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Reinforcing effects of cannabinoids

A
  • CB1 receptors located with dopamine receptors in mesolimbic dopamine pathway regions (midbrain, pfc, basal ganglia)
  • CB1 receptor stimulation decreases inhibitory actions of GABA neurons projecting on to dopamine neurons in the nacc
  • positive dopamine neurons in the ventral tegmental area synthesise & release endocannabinoid when stimulated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Reinforcement via opioid receptors

A
  • CB1 overlap & interact with mew opiod receptors in nacc
  • mew opioid receptor abolishes preference to THC
  • naloxone (opioid antagonist) blocks THC self-administration & THC induced dopamine release in nacc
  • naltrexone decreases cannabis use and positive subjective effects in daily marijuana smokers
  • CB1 reinforce effects and devt of phys dependence of some opioids (morphine & heroin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Low-moderate dose effects on body

A
  • dilation of small blood vessels in eyes
  • dry mouth, thirst
  • hunger (max 3hrs after smoking; tolerance after few weeks)
  • decreased blood pressure @ low doses/repeated use - increases @ high dose
  • body temp changes
  • increased heart rate
  • increased cortisol
  • headache, dizziness, nausea/vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

effects on sleep

A
  • increased dwosiness, decreased time to fall asleep, increased sleeping time, decreased REM
  • high dose = insmonia, chronic use = LT decreased slow wave sleep
  • habitual use, tolerance to sleep-latency but not to REM
  • withdrawal effects: increased time to fall asleep, increased awakenings, decreased total sleep time & quality, vivd dreams, decreased slow-wave sleep, REM rebound
26
Q

effects on perception

A
  • blurred vision
  • usually no change in sensory thresholds (vs subjective report)
  • decreased pain sensitivity
  • slowing in time rate (time distortion effects)
27
Q

effects on memory

A
  • disrupts ability to recall verbal material
  • STM (dose-dependent impairments)
  • temporal disintegration
28
Q

effects on attention

A
  • decreased performance on vigilance tasks/sustained attention
  • decreased concentration
29
Q

effects on creativity

A

no evidence

30
Q

effects on mood

A
  • gaiety (dreaminess)
  • anxiety/panic
  • variability in subjective mood and arousal ratings
  • depends on environment & mood of others
31
Q

effects on performance

A
  • variable
  • depends on experience, instruction, motivation, setting, dose, performance task
  • in general, choice reaction time & complex tasks most impaired; chronic users less impaired than occasional users
32
Q

effects on driving

A
  • decreased performance for most people; potentiated by alcohol
  • decrease ability to attend to peripheral stimuli
33
Q

medically beneficial effects

A
  • decrease nausea/vomiting - cancer treatments
  • anticonvulsant & spasticity
  • modulating pain
  • decreased blood pressure in eye glaucoma
34
Q

psychosis - acute effects

A
  • drug induced psychosis
  • distorted perception, anxiety, panic, paranoia, psychotic-like experience
  • CBD may counteract such THC effects
35
Q

psychosis - long-term effects

A

increased risk of psychosis & schizophrenia (can trigger 1st episode; make pre-exising illness worse)

36
Q

flaws in psychosis research

A
  • correlational
  • includes large dose/chronic users
  • small sample sizes
37
Q

lethal doses of THC?

A
  • phylogenetically higher animals are less susceptible to acute toxicity of THC
  • no experimental evidence to determine a lethal dose in humans - from animal research LD50 = 65kg adult would be 8.45kg of THC
38
Q

unconditioned physical behaviour in animals

A
  • mice: cannabinoid tetrad dose dependent effect (decreased SMA, muscle rigidity, decreased pain sensitivity & hypothermia)
  • biphasic effect of SMA: increased activity followed by decreased SMA
  • high doses - ataxia
39
Q

unconditioned feeding behaviour in animals

A

dependent on dose, route of admin and timepoint
- inhalation of vapor increases food intake in first hour
- high doses decrease appetite and subsequent weight loss
- increases sweet preference

40
Q

unconditioned behaviour in animals

A
  • decrease in aggression (taming effect)
  • decreased response to painful stimuli (THC as potent as morphine)
41
Q

conditioned behaviour in animals

A
  • THC interferes with STM tasks (correlates with decreased neuronal firing in hippocampus in rats)
  • research mixed on effects on LTM
  • chronic use during adolescence leads to adult deficits in spatial memory & STM
  • decreased avoidance responding but not excape responding
  • does not affect punished responding
42
Q

discrimination (animals)

A
  • reliable discrimination of THC from placebo
  • delta-9-THC gerenralizes to delta-8-THC, nabilone, 11-hydroxy metabolite, CBN
  • partial generalisation to sedatives
  • does not generalize to CBD, anandamide (unless at high doses of anandamide), or drugs from other classes
43
Q

discrimination (humans)

A

humans can discriminate marijuana cigarettes which don’t contain THC after 90 sec inhalation; if THC content is > 0.09%
dissociation in animals & humans

44
Q

self-administration (animals)

A

animals self-administer but not reliably intravenously
- rats will lver-press for THC injections to VTA or NAcc

45
Q

self-administration (humans)

A

humans have fairly stable intake
- titration
- > some studies show titration of dose
- > others show inability to account for different potencies
- may be more reinforcing if higher THC content

46
Q

tolerance (animals)

A
  • develops rapidly (5-6 days) to many effects
  • tolerance develops to the initial SMA but the suppression of SMA is more resistant to tolerance
  • tolerance does not develop to anorexic effects and discrimination
  • lasts for > 1 month and cross-tolerance btwn delta-9-thc and 11-dyroxy metabolite
  • associated with decrease in CB1 receptors
47
Q

tolerance (humans)

A
  • more consistent with high doses and frequent use
  • develops to acute nerucognitive impairment and most subjective psychological effects (downregulation of CB1 receptors)
  • no tolerance to increased food consumption
48
Q

withdrawal (animals)

A
  • in continuous admin of high doses
  • typically mild symptoms
  • symptoms may be masked by long 1/2 life
49
Q

withdrawal (humans)

A

onset 1-3 day pasr abstinence, peaks 2-6 days, lasts for 2 weeks (mild)
- irritability, restlessness, insomnia, anxiety, depressed mood
- hot flashes, swetaing, runny nose, diarrhea, hiccups, decreased appetite
- cravings for cannabis
- oral THC capsules can alleviate symptoms

50
Q

Cannabis use disorder

A
  • 1 in 5 risk of developing and 13% had cannabis dependence
  • risks of developing cannabis dependence increases to 33% if cannibis is intiated early and used frequently
51
Q

effects on reproduction

A
  • Males: decreased testosterone, sex drive, decreased sperm motility
  • females: fertility (anadamide & fertility)
  • increase risk of miscarriage, preterm birth & fetal growth restriction; mild cognitive impairments, attentional & mood disorders in children
  • abnormal sleep pattern of newborns
  • chromosomal damage
52
Q

effects on immune system

A

complex but includes decreased immune functioning

53
Q

effects on respiration

A
  • acute effect: bronchodilation - helpful in asthma
  • repeated cannabis smoking increases inflammation of large airways, increase in airway resistance, & lung damage similar to cigarett smoking
  • decreased activity of macrophages
  • increased risk of respiratory disease associated with smoking, including cancer
54
Q

cancer

A
  • more carcinogens than tobacco
  • inhale more tar than tobacco
  • may accelerate carcinogenic effects of tobacco smoke
  • antioxidant effect of THC and CBD
55
Q

violence

A
  • no empirical evidence; though widely held belief
  • usually show decrease hostility
56
Q

mental disturbance

A

paranoia & anxiety (large doses)
acute psychotic episode
can precipitate psychosis in people with psychotic tendencies

57
Q

brain damage

A
  • loss of mental functioning (mild), dose/recency effects
  • animal research has found altered brai structure and decreased neuronal plasticity & learning
58
Q

amotivational syndrome

A
  • evidence from clinical observations
  • recent studies show acute effects on motivation/choice to engage in less effortful/lower reward tasks over more effortful/higher reward tasks
59
Q

altered reward response in nucleus accumbens

A
  • decreased nacc response to monetary reward anticipation
  • increased mesolimbic response to cannbis cues vs fruit rewards
60
Q

marijuana as a gateway drug

A
  • high correlation but no causal evidence
  • social not physical
  • or personality variables